Managing Diabetes During the Holidays
What’s your strategy for managing your diabetes during the holidays? The Breakthrough T1D-Beyond Type 1 Alliance offers tips to ensure you can enjoy without worry.
NFL Miami Dolphins and Breakthrough T1D Ambassador Blake Ferguson Snaps Hard for Cures!
NFL long snapper for the Miami Dolphins Blake Ferguson is a T1D Champion! Learn how he's helping Breakthrough T1D win in the fight against T1D.
First-in-Human Gene-Edited Stem Cell Trial? Check.
ViaCyte, a beta cell replacement company long supported by Breakthrough T1D, and CRISPR Therapeutics have a new first: Gene-editing for type 1 diabetes.
The Bonds of Family and the Power of Fiction
Author Eve Yohalem interviews her sister about life with type 1 diabetes and the power of fiction to make diabetes a normal part of humanity.
First-in-Human T1D Vaccine Trial Reports Positive Results
A first-in-human study of the coxsackie B vaccine—made by Breakthrough T1D-funded researchers Drs. Hyoty and Knip—reports positive results.
Artificial pancreas systems: Sleeping without fear
Research shows Artificial Pancreas Systems can help improve diabetes-related outcomes and lighten the burden of T1D. Even during sleep.
Smart Insulin Pen/Smart Cap Bridge Technology Gap for MDI
People living with T1D who prefer multiple daily injections (MDI) of insulin now have two high-tech management options: An insulin smart pen or an insulin smart pen cap.
COVID-19 Vaccine Now Available for Children Ages 5+
Late Tuesday evening, Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC), recommended the use of the Pfizer/BioNTech COVID-19 vaccine in children ages 5–11. This decision followed the FDA’s Emergency Use Authorization on Friday, Oct. 29th. That means that if you have a child 5 years of age or older, they […]
Research, Innovation, and Wellness at TypeOneNation Virtual Summit
Help us kick off National Diabetes Awareness Month at TypeOneNation Virtual Summit on November 1, 3, and 4, from 6:00 – 8:00 pm ET. This free event is for people of all ages and stages of type 1 diabetes and their loved ones. We’re offering three nights of sessions covering important topics like Breakthrough T1D’s […]
Vertex Shares Data from Their Stem Cell-Derived Therapy—and It’s Outstanding
In February, Vertex announced they were beginning a clinical trial for VX-880, their stem cell-derived therapy for use in people with type 1 diabetes (T1D). Today, they announced that the first person to receive this therapy now needs 91% less insulin 90 days after receiving an infusion of these fully differentiated cells at just half […]
